These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35851860)

  • 1. Shift in Clinical Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus B Infections in Korean Children Before and During the COVID-19 Pandemic: A Multicenter Retrospective Study.
    Kim YK; Song SH; Ahn B; Lee JK; Choi JH; Choi SH; Yun KW; Choi EH
    J Korean Med Sci; 2022 Jul; 37(28):e215. PubMed ID: 35851860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household Cohort in Maryland.
    Hetrich MK; Oliva J; Wanionek K; Knoll MD; Lamore M; Esteban I; Veguilla V; Dawood FS; Karron RA;
    Clin Infect Dis; 2023 Apr; 76(8):1349-1357. PubMed ID: 36503986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV.
    Haller AA; Mitiku M; MacPhail M
    J Gen Virol; 2003 Aug; 84(Pt 8):2153-2162. PubMed ID: 12867647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials.
    Lee MS; Walker RE; Mendelman PM
    Hum Vaccin; 2005; 1(1):6-11. PubMed ID: 17038832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
    Tang RS; MacPhail M; Schickli JH; Kaur J; Robinson CL; Lawlor HA; Guzzetta JM; Spaete RR; Haller AA
    J Virol; 2004 Oct; 78(20):11198-207. PubMed ID: 15452239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre study on the incidence of respiratory viruses in children with community-acquired pneumonia requiring hospitalization in the setting of the zero-COVID policy in China.
    Feng Z; Xu B; Zhong L; Chen J; Deng J; Luo Z; Cao L; Tang Y; Li C; Jin R; Deng L; Shang Y; Wu Y; Zhao H; Feng Q; Chen X; Xu L; Xie Z
    Arch Virol; 2023 Jan; 168(2):64. PubMed ID: 36639581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric glycoprotein formulated with a combination adjuvant induces protective immunity against both human respiratory syncytial virus and parainfluenza virus type 3.
    Garg R; Brownlie R; Latimer L; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Antiviral Res; 2018 Oct; 158():78-87. PubMed ID: 30071204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs.
    Garg R; Latimer L; Gomis S; Gerdts V; Potter A; van Drunen Littel-van den Hurk S
    Antiviral Res; 2019 Feb; 162():54-60. PubMed ID: 30550799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years.
    Mazela J; Jackowska T; Czech M; Helwich E; Martyn O; Aleksiejuk P; Smaga A; Glazewska J; Wysocki J
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological Characteristics of Respiratory Syncytial Virus Infection Among Hospitalized Children With Acute Respiratory Tract Infections From 2014 to 2022 in a Hospital in Hubei Province, China: Longitudinal Surveillance Study.
    Hu XW; Zhou Y; Yi S; Zhang WX; Wang XR; Du J; Lu QB
    JMIR Public Health Surveill; 2023 Apr; 9():e43941. PubMed ID: 36975172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study.
    Gashgarey D; Alsuhaibani M; Alhuthil R; Alhabshan H; Alabdulqader A; Badran R; Balhmar A; Aldawood H; AlBanyan EA; AlGhamdi S; AlJumaah S; AlYabes O; Al-Hajjar S
    J Epidemiol Glob Health; 2024 Jun; 14(2):319-326. PubMed ID: 38573464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
    Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
    Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine.
    Yang CF; Wang CK; Malkin E; Schickli JH; Shambaugh C; Zuo F; Galinski MS; Dubovsky F; ; Tang RS
    Vaccine; 2013 Jun; 31(26):2822-7. PubMed ID: 23602668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of characteristics of children hospitalized for respiratory syncytial virus infection during the pre- and post-COVID-19 eras: a multicenter retrospective study.
    Liu HF; Wang YY; Zhang XZ; Li HY; Xiang M; Lu R; Liu CY; Li W; Feng QL; Guo YJ; Huang RW; Fu HM
    BMC Infect Dis; 2024 Sep; 24(1):1009. PubMed ID: 39300365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children.
    Bernstein DI; Malkin E; Abughali N; Falloon J; Yi T; Dubovsky F;
    Pediatr Infect Dis J; 2012 Feb; 31(2):109-14. PubMed ID: 21926667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.
    Belshe RB; Newman FK; Anderson EL; Wright PF; Karron RA; Tollefson S; Henderson FW; Meissner HC; Madhi S; Roberton D; Marshall H; Loh R; Sly P; Murphy B; Tatem JM; Randolph V; Hackell J; Gruber W; Tsai TF
    J Infect Dis; 2004 Dec; 190(12):2096-103. PubMed ID: 15551207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
    Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
    Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France.
    Fourgeaud J; Toubiana J; Chappuy H; Delacourt C; Moulin F; Parize P; Scemla A; Abid H; Leruez-Ville M; Frange P
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2389-2395. PubMed ID: 34347190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Respiratory Syncytial Virus Infection in Hospitalized Children Before and During the COVID-19 Pandemic in Thailand.
    Chaiut W; Sapbamrer R; Dacha S; Sudjaritruk T; Parwati I; Sumarpo A; Malasao R
    J Prev Med Public Health; 2023 May; 56(3):212-220. PubMed ID: 37287198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and epidemiological characteristics of acute respiratory virus infections in Vietnamese children.
    Tran DN; Trinh QD; Pham NT; Vu MP; Ha MT; Nguyen TQ; Okitsu S; Hayakawa S; Mizuguchi M; Ushijima H
    Epidemiol Infect; 2016 Feb; 144(3):527-36. PubMed ID: 26145204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.